U.S. Leading Ophthalmic Diseases Markets

U.S. Leading Ophthalmic Diseases Markets

 

RELEASE DATE
20-May-2002
REGION
North America
Research Code: A172-01-00-00-00
SKU: HC00825-NA-MR_04522
AvailableYesPDF Download
$3,950.00
In stock
SKU
HC00825-NA-MR_04522
$3,950.00
DownloadLink
ENQUIRE NOW

Description

The leading ophthalmic diseases in the U.S. are glaucoma, age-related macular degeneration (AMD), diabetic retinopathy (DR), and cataracts. The market opportunity in these areas is large and untapped, because a significant portion of the patient base is undiagnosed, and there is still a lack of a curative treatment for all of these diseases. This report summarizes, in detail, the demand and business opportunities in each of the four diseases, as well as the research projects ongoing for developing innovative therapies. Altogether, this report gives an excellent overview of what can be expected to happen in the near future in the field of the most important ophthalmic diseases.

Table of Contents

Overview

  • Introduction
  • Market Drivers
  • Market Restraints

Forecasts and Trends

  • Demand Analysis
  • Market and Technology Trends

Frost & Sullivan Market Engineering Awards

  • Brand Awareness Development Award- Bausch & Lomb
  • Technology Innovation Award - Oculex Pharmaceuticals
  • Business Development Strategy Award - Alcon Laboratories
  • Market Penetration Award - Merck & Co.
  • Product Launch Strategy Award - Novartis Ophthalmics

Overview

Forecasts and Trends

Competitive Analysis

  • Introduction
  • Glaucoma Treatments
  • Market Drivers
  • Market Restraints
  • Challenges
  • Market Engineering Analysis

Strategic Recommendations

  • Revenue Forecasts
  • Revenue Forecast Assumptions
  • Demand Analysis
  • Market and Technology Trends
  • Research Directions
  • Pricing Trends
Related Research
The leading ophthalmic diseases in the U.S. are glaucoma, age-related macular degeneration (AMD), diabetic retinopathy (DR), and cataracts. The market opportunity in these areas is large and untapped, because a significant portion of the patient base is undiagnosed, and there is still a lack of a curative treatment for all of these diseases. This report summarizes, in detail, the demand and business opportunities in each of the four diseases, as well as the research projects ongoing for developing innovative therapies. Altogether, this report gives an excellent overview of what can be expected to happen in the near future in the field of the most important ophthalmic diseases.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number A172-01-00-00-00
Is Prebook No